Understanding the Burden of Atopic Dermatitis in Africa and the Middle East
| Author | Al-Afif K.A.M. |
| Author | Buraik M.A. |
| Author | Buddenkotte J. |
| Author | Mounir M. |
| Author | Gerber R. |
| Author | Ahmed H.M. |
| Author | Tallman A.M. |
| Author | Steinhoff M. |
| Available date | 2020-03-18T10:47:16Z |
| Publication Date | 2019 |
| Publication Name | Dermatology and Therapy |
| Resource | Scopus |
| ISSN | 21938210 |
| Abstract | Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intensely pruritic lesions. The prevalence of atopic dermatitis is increasing in developing regions, including Africa and the Middle East. However, these regions are underrepresented in the dermatology literature, and a better understanding of the growing burden of atopic dermatitis in Africa and the Middle East is necessary. Herein, we summarize current knowledge on atopic dermatitis epidemiology, disease burden, and treatment options in Africa and the Middle East, highlighting the unmet needs of patients in these regions. With these needs in mind, we provide clinical recommendations for appropriate management of atopic dermatitis in Africa and the Middle East. Funding: Pfizer Inc. Plain Language Summary: Plain language summary available for this article. |
| Sponsor | Editorial/medical writing support under the guidance of the authors was provided by Madeline L. Pfau, PhD, and Corey Mandel, PhD, at ApotheCom, New York, NY, and San Francisco, CA, USA, and was funded by Pfizer Inc., New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines ( Ann Intern Med. 2015;163:461-464). |
| Language | en |
| Publisher | Springer Healthcare |
| Subject | Africa Atopic dermatitis Middle East Prevalence Quality of life Therapeutics |
| Type | Article Review |
| Pagination | 223-241 |
| Issue Number | 2 |
| Volume Number | 9 |
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [1549 items ]